Role of Gut Microbiome in Cancer Therapy
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorMayo Clinic
About this trial
This study examines how gut microbiome can affect cancer therapy in cancer patients undergoing cancer therapy or stem cell transplant. The human microbiome affects the way some cancer drugs are metabolized in the human body. Information from this study may help doctors improve the way cancer treatment is delivered, and increase its effectiveness and success.
Eligibility criteria
Qualifiers
Age 18-99
Diagnosis of cancer and undergoing cancer therapy or scheduled to start cancer therapy or undergoing stem cell transplant for any hematological condition
Disqualifiers
Unable to provide informed consent
Vulnerable adults
Trial design
Treatments tested in this trial
- Biospecimen Collection
- Electronic Health Record Review
Treatment groups
3,000 Participants
are divided into 1 treatment groupLocations
3Mayo Clinic in Arizona85259, ScottsdaleArizona, United States
Mayo Clinic in Florida32224, JacksonvilleFlorida, United States
Mayo Clinic in Rochester55905, RochesterMinnesota, United States
Sponsors and collaborators
Mayo Clinic
Lead sponsor
Source ClinicalTrials.gov